May 1, 2026 Trust Stamp provides a comprehensive business briefing for Q1 of 2026 reporting strong progress across multiple business geographies and verticals
May 1, 2026 FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial